Synapse - Susan K Ferrand

Susan K Ferrand

Research Focus

Former Employee. Medicine; Associate Attending

Recent additions – View all

Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement
Meeting Abstract

Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Co-authors at MSK

1

Cohen
1

Comenzo
1

Dhodapkar
1

Feldstein
1

Fleisher
1

Hassoun
1

Kewalra...
1

Klimek
1

Nimer
1

Zhou

Types of Work

Publications

Blood (1)